Mutations in both ITGA2B and ITGB3 genes have been reported in GT patients, including truncating and missense single-nucleotide variants (SNVs), splice defects, in addition to deletions, insertions and inversions.8 Sequencing platelet RNA can be used for mutation screening. This evidence concerns the gene ITGB3 and Glanzmann thrombasthenia 1.